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Adipocyte differentiation is orchestrated by multiple
signaling pathways and a temporally regulated
transcriptional cascade. However, the mechanisms
by which insulin signaling is linked to this cascade
remain unclear. Here we show that the Med23
subunit of the Mediator Complex and its interacting
transcription factor Elk1 are critical regulators of
adipogenesis. Med23/ embryonic fibroblast cells
were refractory to hormone-induced adipogenesis.
Knockdown of either Med23 or Elk1, or overexpres-
sion of dominant-negative Elk1, inhibited adipogene-
sis. In the absence of either Elk1 or Med23, Krox20,
an immediate early gene stimulated by insulin during
adipogenesis, was uninducible. Moreover, the adi-
pogenic defect inMed23-deficient cells was rescued
by ectopic expression of Krox20 or one of its down-
stream factors, C/EBPb or PPARg. Mechanistically,
the insulin-stimulated, Med23-deficient preinitiation
complex failed to initiate robust transcription of
Krox20. Collectively, our results suggest that Med23
serves as a critical link transducing insulin signaling
to the transcriptional cascade during adipocyte
differentiation.
INTRODUCTION
Understanding the molecular basis underlying adipocyte
differentiation is crucial for better management of obesity and
its associated diseases, the prevalence of which have escalated
worldwide in recent years (Rosen and Spiegelman, 2006).
Regulation of adipogenesis involves signaling by multiple extra-
cellular factors and a temporally regulated transcription cascade
(Rosen and MacDougald, 2006; Rosen and Spiegelman, 2006).
Although these multiple signaling pathways can either positively
or negatively regulate adipogenesis (Farmer, 2006), insulin
signaling plays a critical role in promoting lipid accumulation
and energy storage. It has been previously demonstrated
that insulin transiently activates MAPK signaling (Bost et al.,
2005; Porras et al., 1992; Prusty et al., 2002) and the expression
of several rapid response genes during the early phase of764 Developmental Cell 16, 764–771, May 19, 2009 ª2009 Elsevier Iadipogenesis (Farmer, 2006). However, themechanismbywhich
insulin-MAPK signaling transmits information to the adipogenic
transcription cascade still remains unclear (Rosen and
MacDougald, 2006).
The Mediator Complex is a multiprotein complex that bridges
gene-specific transcription factors and the basal transcription
machinery. Different transcription factors, in response to
environmental and developmental cues, physically interact
with different Mediator subunits to control specific genes and
biological processes (Malik and Roeder, 2005). The Mediator
Med23 (Sur2) subunit was originally identified as a genetic
suppressor of a hyperactive ras phenotype in C. elegans (Singh
and Han, 1995). In vivo and in vitro studies have demonstrated
a specific interaction between mammalian Med23 and the
ternary complex factor Elk1, which is activated by MAPK
signaling (Stevens et al., 2002; Wang et al., 2005). Gel filtration
chromatography and immunoprecipitation (IP) revealed that
Med23/ cells contain a stableMediator Complex that supports
the transcription of most genes (see Figure S1 available online)
(Stevens et al., 2002;Wang et al., 2005). Furthermore, microarray
analyses revealed a small set of genes that are downregulated in
Med23/ cells (Stevens et al., 2002; Wang et al., 2005), sug-
gesting that Med23 may regulate specific cellular functions.
Because the Ras-MAPK pathway has been shown to be involved
in insulin signaling and adipogenesis, in this study we investi-
gated the biological function ofMed23 and the possible involve-
ment ofMed23 and Elk1 in the regulation of insulin signaling and
adipogenesis. We found that bothMed23 and its binding partner
Elk1 are regulators of adipogenesis. By controlling the expres-
sion of Krox20 (Egr2), the first transcription factor induced during
adipogenesis (Chen et al., 2005; Gonzalez, 2005), the MAPK-
activated Elk1-Med23 interaction functions as a critical link
that connects insulin signaling to the adipogenic transcriptional
cascade.
RESULTS
Med23 Is Required for Hormone-Induced Adipogenesis
TheMed23/(KO)micewere embryonic lethal around 10.5 days
of gestation (data not shown). Therefore, the embryonic fibro-
blasts (MEFs) were prepared from day 9.5 wild-type (WT)
and KO mouse embryos, self-immortalized, and subjected to
the standard hormone induction of adipogenesis. A three-
hormone cocktail (insulin, 3-isobutyl-1-methylxanthine [IBMX],nc.
Developmental Cell
Med23 Links Insulin Signaling to Adipogenesisand dexamethasone [Dex]) induced a small amount of lipid accu-
mulation in WT MEFs, but not in KO MEFs (Figure 1A). Troglita-
zone, a diabetes drug that promotes glucose uptake and fat
accumulation, efficiently potentiated hormone-induced adipo-
genesis in WT MEFs (over 20%), but failed to do so in KO
MEFs (Figure 1A). As confirmed by real-time PCR, expression
of the adipocyte markers aP2, adipsin, and PPARg at different
time points postinduction was increased in wild-type cells, but
not in KO cells (Figure 1B). It has been previously shown that
BMP4 promotes the differentiation of mesenchymal stem cells
into adipocytes (Tang et al., 2004). Similarly, we observed that
pretreatment of cells with BMP4, followed by the application of
troglitazone and the hormone cocktail, was highly potent in
converting WT MEFs into adipocytes (over 80%). However,
this powerful treatment failed to induce adipogenesis in KO cells
(Figure 1A), suggesting that Med23-deficient MEFs are refrac-
tory to hormone-induced adipogenesis.
Figure 1. Med23 Deficiency Results in De-
fects in Adipogenesis
(A) WT MEFs and KO MEFs were treated as
indicated. At day 8 postinduction, the cells were
stained for lipid droplets with ORO. Scale bar,
100 mm.
(B) WT MEFs and KO MEFs were treated with
insulin, IBMX, and Dex plus troglitazone. At
different time points posttreatment, total RNA
samples were extracted and subjected to real-
time PCR analysis of PPARg, aP2, and adipsin.
Expression was normalized to EF2 mRNA expres-
sion.
(C) 3T3-L1 cells were coinfected with retroviruses
encoding either hMED23 or GFP and retroviruses
encoding either a Med23-specific (si-Med23) or
control siRNA and then selected for hygromycin
and puromycin resistance. A western blot was
used to confirm both the siRNA-mediated knock-
down of endogenous Med23 expression and the
ectopic expression of hMED23. The anti-TBP
blot was included as a control.
(D) Hormone-induced adipogenesis of si-Ctrl,
si-Med23, and si-Med23+hMED23 3T3-L1 cells.
At day 8 postinduction, cells were stained for lipid
droplets with ORO. Scale bar, 100 mm.
(E) Real-time PCR analysis of the expression of
PPARg, aP2, and adipsin in 3T3-L1 cells at
different time points postinduction. The expres-
sion was normalized to EF2 mRNA expression.
To further verify that Med23 plays an
essential role in adipogenesis, Med23
expression was reduced in 3T3-L1 prea-
dipocytes by RNAi. A stable Med23
knockdown cell line was established by
retrovirus-mediated siRNA delivery in
3T3-L1 cells. A control cell line express-
ing a negative control oligonucleotide
was generated in a similar manner.
Following selection with puromycin, the
cells were cultured to confluence and
treated with the hormone cocktail. The
MED23 protein level in the si-Med23 cells was reduced by
approximately 90% compared with that of the control cell line
(Figure 1C). Oil Red O (ORO) staining demonstrated that
si-Med23 cells accumulated far fewer lipids than the control cells
(Figure 1D), and real-time PCR confirmed the greatly attenuated
expression of adipocyte markers in si-Med23 cells during differ-
entiation (Figure 1E). To exclude off-target effects of the siRNA,
the humanMed23 gene, which is resistant to the siRNA specific
for the mouse Med23, was reintroduced into the si-Med23 cell
line using retroviral transduction. Cells with the incorporated
gene were selected with hygromycin and then induced to differ-
entiate. Ectopic expression of human MED23 partially rescued
the defective adipogenesis in the si-Med23 3T3-L1 cells, as
assessed by ORO staining and the expression of aP2, PPARg,
and adipsin (Figures 1C, 1D, and 1E). Collectively, the experi-
ments in both the MEFs and the 3T3-L1 cells demonstrate that
Med23 is essential for hormone-induced adipogenesis.Developmental Cell 16, 764–771, May 19, 2009 ª2009 Elsevier Inc. 765
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(A) Stable 3T3-L1 cell lines were generated by
retroviral expression of an Elk1-specific siRNA
(si-Elk1) or a control oligo (si-Ctrl). After puromycin
selection, the cell lysates were analyzed by
western blot.
(B) Inhibition of adipocyte differentiation by Elk1
knockdown. si-Elk1 and si-Ctrl cells were cultured
to confluence, induced to differentiate, and
stained with ORO at day 8 postinduction. Scale
bar, 100 mm.
(C) Reduced expression of adipocyte markers
following Elk1 knockdown. Total mRNA was
prepared from samples taken at the indicated
time point postinduction and analyzed using real-
time PCR. The expression was normalized to
EF2 mRNA expression.
(D) Ni-NTA-immobilized His-FLAG-Med23 was
incubated at 4C overnight with purified GST-
ELK1 or Erk2-treated GST-ELK1. After being
washed, the bound proteins were eluted by boiling
and immunoblotted with the indicated antibodies.
(E) Co-IP of ELK1 with MED23. Plasmids encoding
FLAG-Elk1 and Myc-Med23 were cotransfected
into 293T cells with or without a Mekk expression
plasmid. Whole-cell extracts were generated,
immunoprecipitated with an anti-FLAG antibody,
and analyzed by western blot using an anti-MYC
antibody.
(F) 293T cells were transfected with a 5 3 Gal-
E1B-TATA-luciferase reporter construct and a
plasmid encoding the Gal4-Elk1 activation domain
or Gal4-Elk1 mutants, with or without a Mekk
expression plasmid. The Firefly luciferase activity
was normalized to Renilla luciferase activity. Error
bars represent the standard deviation of three
independent experiments.
(G) 3T3-L1 cell lines stably expressing wild-type
Elk1 (Elk1), the S383A/S389A mutated Elk1 (Elk1
mt), or GFP (GFP) were generated. After hygromy-
cin selection, cell lysateswere analyzed bywestern
blot.
(H) Cells were cultured to confluence, induced
to differentiate, and stained with ORO at day 8
postinduction. Scale bar, 100 mm.
(I) The expression of adipocyte markers was
examined by real-time PCR. The expression is
normalized to EF2 mRNA expression.Elk1 Regulates Adipogenesis
Elk1 is a member of the ternary complex factor family. Upon
phosphorylation by MAPK, ELK1 interacts with the Mediator
Complex via the Med23 subunit (Cantin et al., 2003; Stevens
et al., 2002; Wang et al., 2005) and therefore is considered
upstream of Med23. Although Elk1 has been shown to be
involved in proliferation and neuronal differentiation (Buchwalter
et al., 2004), its role in adipogenesis has not yet been reported.
We established a 3T3-L1 cell line stably expressing an Elk1-
specific siRNA (Figure 2A) and observed attenuated hormone-
induced adipogenesis, as detected by decreased ORO staining
and adipocyte marker gene expression (Figures 2B and 2C).
A similar observation was made in MEFs expressing the Elk1-
specific siRNA (data not shown).766 Developmental Cell 16, 764–771, May 19, 2009 ª2009 Elsevier INext, we further characterized the ELK1 and MED23 interac-
tion. The MED23 protein is highly hydrophobic, and soluble
recombinant MED23 has been difficult to obtain. However, it is
now possible to express and purify a soluble form of tagged
MED23 protein from baculovirus-infected insect cells. In vitro,
only the Erk-phosphorylated GST-ELK1 activation domain
bound to the immobilizedMED23 protein, whereas the nonphos-
phorylated GST-ELK1 did not (Figure 2D). In 293T cells, a weak
interaction between ELK1 and MED23 was detected when
Myc-Elk1 and Flag-Med23 expression plasmids were cotrans-
fected. However, a much stronger interaction between ELK1
and MED23 was observed when a plasmid expressing active
Mekk was also cotransfected (Figure 2E). These results suggest
that phosphorylation of ELK1 facilitates its binding to MED23.nc.
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the ELK1 phosphorylation sites that are important for MAPK acti-
vation. Simultaneous mutation of two serine residues (S383 and
S389) in the ELK1 activation domain to alanine significantly in-
hibited the activity of ELK1 in a luciferase assay (Figure 2F).
We further analyzed the adipogenic phenotypes of 3T3-L1 cells
overexpressing GFP, Elk, or Elk1 mutant (Figure 2G). Overex-
pression of either Elk1 or the S383A/S389A mutant (Elk1-mt) in
3T3-L1 cells slowed down cell growth and inhibited adipogene-
sis (Figures 2G and 2H). However, the generation of adipocytes
from cells expressing Elk1-mt was more severely reduced (5%)
compared with that from cells expressing wild-type Elk1 (30%;
Figures 2G and 2H). The morphological result was confirmed by
the real-time PCR-based quantification of adipocyte markers
(Figure 2I). Thus, theS383A/S389Amutant displayedcharacteris-
tics of a dominant-negativemutant. Taken together, these results
suggest that Elk1 is an important regulator of adipogenesis.
Effect of Med23 Deficiency on Insulin Signaling
and Cell Cycle Progression
In an effort to understand the mechanism by whichMed23 regu-
lates adipogenesis, we examined whether or not Med23 defi-
ciency affects insulin signaling and cell cycle regulation.
AlthoughMed23 is an effector of growth signaling and is required
for adipogenesis, siRNA knockdown of Med23 did not alter
insulin-activated signaling, as indicated by the equal expression
and phosphorylation levels of AKT, ERK, and ELK1 in the si-Ctrl
and si-Med23 3T3-L1 cells following insulin stimulation
(Figure S2A, compare lanes 2 and 4). Interestingly, however,
the basal phosphorylation level of ERK and AKT appeared to
change, possibly due to crosstalk or feedback regulation
(Figure S2A, compare lanes 1 and 3). Importantly, the Med23
knockdown did not change the expression pattern of cell cycle
regulators such as cyclin A, E, and D in a 24 hr time period after
hormone induction (Figure S2B).
Postconfluent 3T3-L1 cells typically undergo one or two
rounds of the cell cycle upon adipogenic hormone induction
(mitotic clonal expansion), which is considered a prerequisite
step for 3T3-L1 differentiation (Otto and Lane, 2005). It has
been previously shown that MAPK signaling is required to initiate
this mitotic clonal expansion during adipogenesis (Tang et al.,
2003). However, knockdown of either Elk1 or Med23 in 3T3-L1
cells did not change cell doubling or cell cycle progression in
response to the induction of adipogenesis by the three
hormones (Figure S3). This suggests that Elk1 and Med23
most likely regulate adipogenesis by mechanisms other than
an effect on insulin signaling, cell cycle progression, or mitotic
clonal expansion.
Insulin-MAPK-Elk1-Med23 Pathway Targets Krox20
to Modulate the Adipogenic Transcription Cascade
In previous studies using microarrays and chromatin IP (ChIP)
assays, it has been demonstrated that the Elk1-Med23 interac-
tion controls the expression of the early growth response genes,
including Krox20, in response to serum growth factor (Wang
et al., 2005). Krox20 is highly expressed in adipose tissues (Sou-
kas et al., 2001) and is the first transcription factor expressed
upon insulin stimulation during adipocyte differentiation,
although the mechanism of how insulin induces Krox20 expres-Devesion is not clear (Chen et al., 2005; Gonzalez, 2005). Therefore, to
better understand how Med23 controls adipogenesis and how
insulin signaling affects Krox20 expression, we investigated
whether Med23 also controls insulin-stimulated Krox20 expres-
sion in the early phase of adipocyte differentiation. RNA samples
were collected from confluent WT and KOMEFs at different time
points after insulin stimulation and analyzed by real-time PCR.
Consistent with the previous report (Chen et al., 2005), in WT
cells the expression of Krox20 was rapidly induced by insulin,
reached a peak 30 min poststimulation, and decreased to the
basal level 60 min poststimulation. However, this induction
was abolished in KO cells (Figure 3A). Krox20 seems to be
specifically induced by insulin, because insulin treatment with
or without the other two hormones (IBMX and Dex) did not alter
the intensity of Krox20 induction (data not shown). Consistent
with the fact that Elk1 regulates adipogenesis, insulin-stimulated
expression of Krox20 was also greatly reduced in cells following
knockdown of Elk1 (Figure S4) or overexpression of a dominant-
negative Elk1mutant (data not shown). These data demonstrate
that both Elk1 and Med23 control insulin-stimulated Krox20
expression.
To determine the specific effect of the insulin-MAPK-Elk1-
Med23 pathway on Krox20 expression, we treated the cells
with various inhibitors of signal transduction during insulin induc-
tion (Figure 3B). Only a MEK1 inhibitor, U0126, selectively in-
hibited the insulin-mediated expression of Krox20 in WT MEFs;
inhibitors specific to other signaling pathways, including
SB203580 (to p38), H-89 (to PKA), and LY294002 (to PI3K) did
not inhibit insulin-stimulated Krox20 expression. Interestingly,
the inhibition of p38 further enhanced the insulin-induced
expression of Krox20, possibly due to the crosstalk between
p38 and Erk (Keeton et al., 2003). In KO cells, none of the inhib-
itors had an obvious effect on the low level of Krox20 expression,
because deletion of Med23 already abolished the Krox20
response to insulin (Figure 3B). These data suggest that
insulin-induced expression of Krox20 is MAPK dependent and
that Med23 is required for connecting insulin-MAPK signaling
to Krox20 gene activation.
It has been previously reported that following insulin-activated
expression of Krox20, both C/EBPb (Farmer, 2006) and KLF5
(Oishi et al., 2005) are expressed during the early phase of adipo-
genesis. Therefore, we tested whether C/EBPb and KLF5 are
also affected by Med23 in WT and KO MEFs. To eliminate the
mixed effects of multiple hormones, the cells were treated with
insulin alone (without IBMX and Dex). The mRNA expression
level of both C/EBPb and KLF5 in WT MEFs was modestly
increased after insulin treatment. Expression reached the peak
level (2- to 3-fold induction) 2 hr poststimulation and then re-
turned to the basal level 4 hr poststimulation (Figures 3C and
3D). In contrast, in KO MEFs the expression level of both C/
EBPb and KLF5 did not change significantly throughout the
time course, and a reduced basal level of expression was
observed (Figures 3C and 3D). This suggests that loss of
Med23 attenuates both the insulin-induced and basal level
expression of C/EBPb and KLF5. These results demonstrate
that Med23 not only controls the MAPK-dependent expression
of an early immediate gene, Krox20, but also modulates down-
stream adipogenic transcription factors. Furthermore, because
PPARg expression was also abolished in KO cells (Figure 1B),lopmental Cell 16, 764–771, May 19, 2009 ª2009 Elsevier Inc. 767
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scriptional program.
Ectopic Expression of Krox20 or Its Downstream
Factors Rescues the Adipogenic Defect in Med23-
Deficient Cells
Our data suggest that Med23 acts upstream of Krox20 and the
adjunct adipogenic transcription cascade. Therefore, we expect
that overexpression of Krox20 should reverse the defect in
adipogenesis resulting from Med23 deficiency. To test this,
si-Med23 3T3-L1 cells were infected with a retrovirus encoding
Krox20 and the hygromycin-resistance gene for selection
(Figure 3E). As shown in Figures 3F and 3G, overexpression of
Krox20 rescued the differentiation defect of si-Med23 3T3-L1
cells, as indicated by ORO staining and real-time PCR analysis
Figure 3. Med23 Controls the Insulin-Stim-
ulated Krox20 Expression
(A) Krox20 expression at the indicated time points
following insulin induction.
(B) Insulin-stimulated expression of Krox20 is
selectively blocked by a MAPK inhibitor. Inhibitors
of various signaling pathways were added to the
culture medium 30 min before insulin application.
Total RNA samples were harvested 30 min after
insulin addition. Error bars represent the standard
deviation of three independent experiments.
(C and D) Real-time PCR analysis of the expres-
sion of C/EBPb and KLF5 at the indicated time
points following insulin induction (without IBMX/
Dex). The expression is normalized to EF2 mRNA
expression.
(E) si-Med23 3T3-L1 cells were infected with
a retrovirus encoding the Krox20 cDNA and
selected with hygromycin. Real-time PCR was
used to quantify the Krox20 expression level of
the indicated cell lines. The expression is normal-
ized to EF2 mRNA.
(F) Hormone-induced adipogenesis of si-Ctrl,
si-Med23, and si-Med23+Krox20 3T3-L1 cells. At
day 8 postinduction, cells were stained for lipid
droplets with ORO. Scale bar, 100 mm.
(G) Real-time PCR analysis of the expression
level of adipocyte markers in the indicated
3T3-L1 cell lines at different time points postinduc-
tion. The expression is normalized to EF2 mRNA
expression.
of adipocyte marker gene expression.
Additionally, forced expression of
Krox20 in the KO MEFs also partially
restored hormone-induced adipogenesis
(data not shown).
Because Elk1 and Med23 may regulate
the expression of other genes besides
Krox20, it is possible that other Med23-
regulatedgenes are also involved in adipo-
genesis. Therefore, a gene profiling exper-
iment was performed in the si-Ctrl and
si-Med23 3T3-L1 cells, and a small
number of genes (34) were identified that
are both Med23 regulated and insulin
responsive (Table S1). Krox20 was the most insulin-responsive
(11.9-fold induction)of the34genes identified.Althoughwecannot
rule out thepossibility thatoneof theothergenesmayalso regulate
adipogenesis, the facts that Krox20 overexpression rescues adi-
pogenesis in Med23-deficient cells and that Krox20 knockdown
blocks adipogenesis in both 3T3-L1 and NIH 3T3 cells (Chen
et al., 2005) suggest that Krox20 is an essential factor connecting
insulin signaling to adipogenesis. We also noticed that another
transcription factor,Egr1, which is a closely related familymember
of Krox20 that is also targeted by Med23 (Wang et al., 2005), is
significantly induced by insulin (Table S1). However, in contrast
to the effect ofKrox20, ectopic expression of Egr1 failed to restore
hormone-induced adipogenesis in the si-Med23 3T3-L1 cells
(Figure S5), which further underscores the specific role of Krox20
in the adipocyte lineage.768 Developmental Cell 16, 764–771, May 19, 2009 ª2009 Elsevier Inc.
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genic transcription cascade, we tested whether factors down-
stream of Krox20 (C/EBPb and PPARg) are able to reverse the
adipogenic defect inMed23-deficient cells. To address this ques-
tion, KO MEF cell lines stably expressing C/EBPb or PPARg were
generated. A GFP-expressed cell line was also generated as a
control. These cells were cultured to confluence and then
subjected tohormone-induceddifferentiation.Theectopicexpres-
sion ofC/EBPborPPARg in KOcells robustly promotedadipogen-
esis (>90%) and adipogenic marker gene expression (Figure S6).
These results further support that Krox20, C/EBPb, and PPARg
are downstream of Med23, because ectopic expression of any
one of them is able to bypass the need forMed23 in adipogenesis.
Med23 Is Required for the Productive Transcription
of Krox20 in Response to Insulin Stimulation
To determine how Med23 controls insulin-MAPK-activated
Krox20 transcription, ChIP experiments were performed to
Figure 4. Effect of Insulin on the Binding of
ELK1, Mediator, and Pol II to the Krox20
Promoter
3T3-L1 cells were grown to confluence and then
treated with insulin at a final concentration of 5
mg/ml for 30 min. ChIP experiments were per-
formed using antibodies against Elk1 (A), the
Mediator Complex (Med1 and Med17) (B), Pol II
(C and D), TBP (E), TFIIE (F), and IgG as a control.
The precipitated DNA was analyzed by real-time
PCR with primers targeting the Krox20 promoter
region (Krox20p) and coding region (Krox20c).
The primer sequences are provided in Table S2.
The relative binding level of each factor was calcu-
lated by normalization to the input DNA. The mean
of three separate experiments is shown, and the
standard deviation is indicated. Student’s t test,
*p < 0.05, **p < 0.01.
measure the binding of ELK1, the Medi-
ator Complex, Pol II, and general tran-
scription factors to the Krox20 locus in
response to insulin in confluent si-Ctrl,
si-Elk1, and si-Med23 3T3-L1 cells. Both
ELK1 and TBP constitutively bind to the
Krox20 promoter, but not to the coding
region, at an equivalent level regardless
of Med23 status and insulin application
(Figures 4A and 4E). This most likely indi-
cates that they function as the platform
for the formation of the preinitiation
complex (PIC). The knockdown of Elk1
reduced ELK1 binding at the Krox20
promoter by 50% (Figure S7A), which
led to a 50% decrease in both the basal
and the insulin-stimulated levels of the
Mediator Complex binding at the Krox20
promoter (Figure S7B). Consistent with
the in vivo and in vitro data demonstrating
that phosphorylated ELK1 interacts with
MED23 (Figures 2D, 2E, and 2F), the
addition of insulin enhanced the co-occupancy of ELK1 and
Mediator at the Krox20 promoter (6-fold increase), as detected
in a sequential ChIP (re-ChIP) experiment (Figure S7C). These
results suggest that recruitment of the Mediator Complex at
the Krox20 promoter is dependent on ELK1 and insulin stimula-
tion. Consistently, insulin stimulation increased the binding of the
Mediator Complex, Pol II, and TFIIE at theKrox20 promoter (3- to
6-fold increase) in si-Ctrl 3T3-L1 cells (Figures 4B, 4C, and 4F).
The level of Pol II binding at the Krox20 promoter in the presence
of insulin and Med23 is comparable to that at the promoter of
a constitutively expressed gene, EF2, but is significantly above
that at the promoter of an inactive gene, IL12b (Figure S8). Inter-
estingly, in the si-Med23 cells, there seems to be aMed23-inde-
pendent enhancement of Pol II and TFIIE binding to the Krox20
promoter (approximately 1-fold increase) upon insulin stimula-
tion (Figures 4C and 4F), and Mediator Complex binding is also
slightly increased (Figure 4B). These enhancements are probably
not due to the residual amount of Med23, because similarDevelopmental Cell 16, 764–771, May 19, 2009 ª2009 Elsevier Inc. 769
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observed in the insulin-stimulated KO MEFs (Figures S9B and
S9C). However, only in the WT cells, and not in theMed23-defi-
cient cells, Pol II at the Krox20 promoter was able to initiate tran-
scription efficiently, as indicated by the enhanced Pol II binding
to the Krox20 gene coding region in the presence of insulin
(Figure 4D and S9D) and the greatly enhanced Krox20 mRNA
level (Figure 3A). Taken together, these data suggest that insulin
stimulation and Med23 are both required for significant recruit-
ment of Pol II and active transcription from the Krox20 promoter.
Upon insulin stimulation, the Elk1-Med23 interaction promotes
a productive PIC that leads to robust transcription, whereas
the Med23-deficient PIC fails to do so.
DISCUSSION
This report demonstrates that the Mediator Complex subunit
Med23andElk1arepivotal regulatorsofadipogenesis.Bycontrol-
ling insulin-MAPK-stimulated expression of Krox20, Med23 con-
nects the insulin signaling pathway to the adipogenic transcription
cascade. Our study reveals a function of the Elk1-Med23-Krox20
axis in regulating adipocyte formation, adding Elk1 andMed23 to
the growing list of key early regulators of adipogenesis, such as
Krox20 (Chen et al., 2005), Klf5 (Oishi et al., 2005), Klf4 (Birsoy
et al., 2008), and CREB (Reusch et al., 2000; Zhang et al., 2004).
Collectively, these studies suggest the existence of an early tran-
scriptional factor network that initiates the adipogenesis program,
and Elk1/Med23may represent the earliest point of regulation.
The effect ofMed23 in adipogenesis is highly specific, because
Med23 deficiency does not prevent the differentiation of embry-
onic stem cells intomany other cell types of the three germ layers
during embryoid body and teratoma formation (data not shown).
Furthermore, knockdown ofMed23 in C2C12 myoblasts did not
inhibit induced skeletal myogenesis (Figure S10), emphasizing
the specific role forMed23 in adipogenesis. Because the deletion
ofMed23 is embryonic lethal, the in vivo function ofMed23during
adipogenesis awaits future study using a conditional knockout
approach.
Growing evidence has demonstrated that the Mediator
Complex functions as a control center in directing diverse bio-
logical processes. For example, another Mediator subunit,
Med1, controls adipogenesis by binding to PPARg, a transcrip-
tion factor that is critical for the terminal stage of adipocyte differ-
entiation (Ge et al., 2002). Other Mediator subunits are required
for different biological functions, such as Med12 for regulating
neuronal development (Wang et al., 2006) orMed15 for control-
ling TGFb signaling during development (Kato et al., 2002) and
SREBP-controlled cholesterol and fatty acid homeostasis
(Yang et al., 2006). Modulation of the various interactions
between different activators and Mediator subunits may provide
novel strategies tomanipulate these diverse biological functions.
Importantly, the Elk1-Med23 interaction may represent a poten-
tial therapeutic target for obesity and its associated diseases.
EXPERIMENTAL PROCEDURES
Cell Culture and Adipocyte Differentiation
Differentiation of MEFs and 3T3-L1 into adipocytes was described previously
(Chen et al., 2005; Ge et al., 2002). For more detail, including methods for770 Developmental Cell 16, 764–771, May 19, 2009 ª2009 Elsevierinsulin stimulation and signaling inhibition, see Supplemental Experimental
Procedures.
Retrovirus Plasmids and Infection
Establishing stable cell lines to knock down or overexpress a gene of interest
were based on the manufacturer’s recommendation (Clontech). For more
detail, see Supplemental Experimental Procedures.
Real-Time PCR and Western Blot Analysis
Methods for Real-time PCR and western blot analysis were described previ-
ously (Wang et al., 2005). See Supplemental Experimental Procedures for
more detail.
Recombinant Protein Production, In Vitro Binding, and Co-IP
See Supplemental Experimental Procedures.
Site-Specific Mutagenesis and Luciferase Assay
Multiple serine residues within the Elk1 activation domain of Gal4-Elk1 (307–
428) were mutated by site-directed mutagenesis to alanine residues using
the KOD Hot Start DNA Polymerase kit (TOYOBO). Cotransfection and lucif-
erase assay are described in the Supplemental Experimental Procedures.
ChIP
ChIP assays were performed as described previously (Wang et al., 2005);
however, the immunoprecipitated DNA was quantified using real-time PCR.
The primers for analyzing the ChIP DNA are provided in Table S2. More detail
is offered in the Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, ten
figures, and two tables and can be found with this article online at http://
www.cell.com/developmental-cell/supplemental/S1534-5807(09)00168-3.
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